Financial Post
🏢 Postmedia
📍 BC
Jul 20, 2026
· 1 min read
AI Analyzed
○ Unverifiable
View full audit trail →
Augurex Abstract Receives ADLM Immunology Abstract Award and Selected for Highlighted ePoster Discussion at ADLM 2026
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · CENTER
ML v2 (DistilBERT)
0.259 · RIGHT
Ensemble
0.130 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.026
3,205 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
Article Excerpt
VANCOUVER, British Columbia — Augurex Life Sciences Corp., a leader in autoimmune biomarker diagnostics, today announced that its scientific abstract, “Anti-14-3-3eta Autoantibodies: A Novel Diagnostic Biomarker that Discriminates Axial Spondyloarthritis from Mechanical Back Pain,” has been selected to receive the Immunology Abstract Award at the 2026 Association for Diagnostics & Laboratory Medicine (ADLM) Conference. The […]
Read full article at Financial Post ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
quick v1
Jul 20, 2026